GM
Therapeutic Areas
Gamma Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GammaCoeur GPF Test | Cardiovascular Disease Risk Assessment (Heart Attack, Stroke) | Commercial |
| GPF Test for Inflammatory Diseases | COVID-19 Severity Prediction | Research/Validation |
Leadership Team at Gamma Diagnostics
CV
Chris Venter
CEO
DD
Dr. David Farrell
Founder and Chief Scientific Officer (CSO)
AN
Ajay Nair
Board Chairman